WELCOME TO MEDINECT OPHTHO
​
Your MEDIcal innovations conNECTed
with preclinical experts
​
Our experienced team works hand-in-hand with you to optimise every stage of your preclinical studies. We align study design with your objectives, using advanced research models to generate reliable, actionable data—so you can make confident decisions and move forward faster.
​
WHO WE ARE
​
MediNect is a specialist preclinical CRO focused exclusively on retinal disease. Our team combines decades of academic R&D with deep procedural expertise to support complex study designs and deliver robust, reliable data.
​
Operating within the UK’s second-largest preclinical ophthalmology suite, we offer agile, high-quality research solutions tailored to accelerate your therapeutic pipeline. Our collaborative approach ensures clear, expert-driven communication at every stage.
EARLY-STAGE PROOF OF CONCEPT SERVICE
Customised POC studies
Guiding your early-stage development with collaborative, expert-driven planning.
LATE-STAGE PROOF OF CONCEPT SERVICE
Advanced-stage POC research
Collaborative design and execution of high-impact late-stage studies.
MECHANISM OF
ACTION SERVICE
Investigatory research
Expert-led support to help you better understand your therapeutic's mechanism of action.
ADME
Pharmacokinetic Profiling Studies
We work alongside you to design PK/PD and distribution studies that clarify how your therapeutic behaves in the body and support strategic decision-making.